Published in Clin Diagn Lab Immunol on March 01, 2002
The past, present, and future of immune repertoire biology - the rise of next-generation repertoire analysis. Front Immunol (2013) 1.22
Human skin cells support thymus-independent T cell development. J Clin Invest (2005) 1.11
Laboratory evaluation of primary immunodeficiencies. J Allergy Clin Immunol (2009) 1.10
Human papillomavirus type 16 E7 peptide-directed CD8+ T cells from patients with cervical cancer are cross-reactive with the coronavirus NS2 protein. J Virol (2003) 1.09
Relative quantification of TCR Vbeta-chain families by real time PCR for identification of clonal T-cell populations. J Transl Med (2008) 1.01
T-cell clonotypes in cancer. J Transl Med (2004) 0.91
High-scatter T cells: a reliable biomarker for malignant T cells in cutaneous T-cell lymphoma. Blood (2010) 0.90
Antigen-driven T-cell selection in patients with cervical cancer as evidenced by T-cell receptor analysis and recognition of autologous tumor. Clin Diagn Lab Immunol (2002) 0.86
A quantitative real time PCR method to analyze T cell receptor Vbeta subgroup expansion by staphylococcal superantigens. J Transl Med (2010) 0.84
Comparison of T-cell receptor repertoire restriction in blood and tumor tissue of colorectal cancer patients. J Transl Med (2010) 0.82
Molecular features of the complementarity determining region 3 motif of the T cell population and subsets in the blood of patients with chronic severe hepatitis B. J Transl Med (2011) 0.82
Autoreactive effector/memory CD4+ and CD8+ T cells infiltrating grafted and endogenous islets in diabetic NOD mice exhibit similar T cell receptor usage. PLoS One (2012) 0.79
A new high-throughput sequencing method for determining diversity and similarity of T cell receptor (TCR) α and β repertoires and identifying potential new invariant TCR α chains. BMC Immunol (2016) 0.76
Cross-Reactivity of TCR Repertoire: Current Concepts, Challenges, and Implication for Allotransplantation. Front Immunol (2016) 0.75
Chemotherapy and radiation therapy elicits tumor specific T cell responses in a breast cancer patient. BMC Cancer (2016) 0.75
Phenotypic analysis of antigen-specific T lymphocytes. Science (1996) 24.26
Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes. Science (1999) 21.24
Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection. Immunity (1998) 17.27
T-cell antigen receptor genes and T-cell recognition. Nature (1988) 16.77
Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma. Nat Med (1998) 11.03
Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells. Nat Med (1998) 7.48
A new era for cancer immunotherapy based on the genes that encode cancer antigens. Immunity (1999) 3.84
T-cell repertoire diversity and clonal expansions in normal and clinical samples. Immunol Today (1995) 3.60
Identification of an MHC class I-restricted autoantigen in type 1 diabetes by screening an organ-specific cDNA library. Nat Med (1999) 3.45
Perturbation of CD4+ and CD8+ T-cell repertoires during progression to AIDS and regulation of the CD4+ repertoire during antiviral therapy. Nat Med (1998) 2.99
Enhanced generation of specific tumor-reactive CTL in vitro by selected Melan-A/MART-1 immunodominant peptide analogues. J Immunol (1998) 2.68
Retracted Regression of human metastatic renal cell carcinoma after vaccination with tumor cell-dendritic cell hybrids. Nat Med (2000) 2.64
Single-cell PCR analysis of TCR repertoires selected by antigen in vivo: a high magnitude CD8 response is comprised of very few clones. Immunity (1996) 2.27
Oligoclonality of tumor-infiltrating lymphocytes from human melanomas. J Immunol (1994) 2.21
Oligoclonal expansions of CD8(+) T cells in chronic HIV infection are antigen specific. J Exp Med (1998) 2.13
An experimentally validated panel of subfamily-specific oligonucleotide primers (V alpha 1-w29/V beta 1-w24) for the study of human T cell receptor variable V gene segment usage by polymerase chain reaction. Eur J Immunol (1992) 2.03
Antigen-selected T-cell receptor diversity and self-nonself homology. Immunol Today (1993) 1.90
Identification of human melanoma peptides recognized by class I restricted tumor infiltrating T lymphocytes. J Immunol (1993) 1.69
Longitudinal phenotypic analysis of human immunodeficiency virus type 1-specific cytotoxic T lymphocytes: correlation with disease progression. J Virol (1999) 1.63
Tetramer-guided analysis of TCR beta-chain usage reveals a large repertoire of melan-A-specific CD8+ T cells in melanoma patients. J Immunol (2000) 1.31
Junctional biases in the naive TCR repertoire control the CTL response to an immunodominant determinant of HSV-1. Immunity (2000) 1.22
The composition of a primary T cell response is largely determined by the timing of recruitment of individual T cell clones. J Exp Med (1999) 1.19
Direct evidence to support the immunosurveillance concept in a human regressive melanoma. J Clin Invest (1994) 1.16
Design and evaluation of antigen-specific vaccination strategies against cancer. Curr Opin Immunol (2000) 1.11
Analogues of CTL epitopes with improved MHC class-I binding capacity elicit anti-melanoma CTL recognizing the wild-type epitope. Int J Cancer (1997) 1.01
New methods for assessing T-cell responses. Clin Diagn Lab Immunol (2000) 1.00
T cell receptor usage of virus-specific CD8 cells and recognition of viral mutations during acute and persistent hepatitis B virus infection. Eur J Immunol (2000) 1.00
Optimal activation of tumor-reactive T cells by selected antigenic peptide analogues. Int Immunol (1999) 0.98
Peptides derived from self-proteins as partial agonists and antagonists of human CD8+ T-cell clones reactive to melanoma/melanocyte epitope MART1(27-35). Cancer Res (1998) 0.95
Clonal expansion of Melan A-specific cytotoxic T lymphocytes in a melanoma patient responding to continued immunization with melanoma-associated peptides. Int J Cancer (2000) 0.95
Analysis of TCR usage in human tumors: a new tool for assessing tumor-specific immune responses. Immunol Today (1995) 0.93
Clonal expansion of T lymphocytes in human melanoma metastases after treatment with a hapten-modified autologous tumor vaccine. J Clin Invest (1997) 0.92
T-cell receptor repertoire in matched MART-1 peptide-stimulated peripheral blood lymphocytes and tumor-infiltrating lymphocytes. Cancer Res (1997) 0.91
Monoclonal TCR mRNA transcripts are preferentially detected in the TCR variable alpha chain in CD8(+) T-lymphocytes: implications for immunomonitoring. Int J Mol Med (1999) 0.86
Cancer vaccine design: a novel bacterial adjuvant for peptide-specific CTL induction. J Immunol (2001) 0.86
Human papillomavirus type 33 E7 peptides presented by HLA-DR*0402 to tumor-infiltrating T cells in cervical cancer. J Virol (2000) 0.79
Clinician's Guide to Prevention and Treatment of Osteoporosis. Osteoporos Int (2014) 5.17
Intratumoral pO2 predicts survival in advanced cancer of the uterine cervix. Radiother Oncol (1993) 3.63
Serotonin reuptake inhibitor discontinuation syndrome: a hypothetical definition. Discontinuation Consensus panel. J Clin Psychiatry (1997) 2.46
Quality of life in allergic rhinitis and asthma. A population-based study of young adults. Am J Respir Crit Care Med (2000) 2.08
The impact of cancer on key relatives: a comparison of relative and patient concerns. Eur J Cancer (1995) 1.84
Antigen-processing machinery breakdown and tumor growth. Immunol Today (2000) 1.82
Tumor oxygenation: a new predictive parameter in locally advanced cancer of the uterine cervix. Gynecol Oncol (1993) 1.79
Identification of human melanoma peptides recognized by class I restricted tumor infiltrating T lymphocytes. J Immunol (1993) 1.69
H-2-restricted cytolytic T lymphocytes specific for HLA display T cell receptors of limited diversity. J Exp Med (1992) 1.64
Close phenotypic and functional similarities between human and murine alphabeta T cells expressing invariant TCR alpha-chains. J Immunol (1997) 1.63
Possible biological mechanisms of the serotonin reuptake inhibitor discontinuation syndrome. Discontinuation Consensus Panel. J Clin Psychiatry (1997) 1.62
Perennial rhinitis: An independent risk factor for asthma in nonatopic subjects: results from the European Community Respiratory Health Survey. J Allergy Clin Immunol (1999) 1.50
Association of bronchial hyperresponsiveness and lung function with C-reactive protein (CRP): a population based study. Thorax (2004) 1.49
Discontinuation symptoms and psychotropic drugs. Lancet (2000) 1.49
Evaluation and modification of commercial infra-red transducers for leaf temperature measurement. Adv Space Res (1998) 1.49
Identification of major epitopes of Mycobacterium tuberculosis AG85B that are recognized by HLA-A*0201-restricted CD8+ T cells in HLA-transgenic mice and humans. J Immunol (2000) 1.48
Systemic lupus erythematosus presenting as mania. Acta Psychiatr Scand (2000) 1.47
TAP off--tumors on. Immunol Today (1997) 1.43
[Mortality by respiratory disease in ten European and North American countries (1979-1990)]. Rev Mal Respir (1996) 1.41
PHARMAC complicates treatment of glaucoma. N Z Med J (1999) 1.40
Engineered secreted T-cell receptor alpha beta heterodimers. Proc Natl Acad Sci U S A (1991) 1.30
Toxoplasma gondii down-regulates MHC class II gene expression and antigen presentation by murine macrophages via interference with nuclear translocation of STAT1alpha. Eur J Immunol (2001) 1.30
Interleukin-7 or interleukin-15 enhances survival of Mycobacterium tuberculosis-infected mice. Infect Immun (2000) 1.29
Helicobacter pylori: clonal population structure and restricted transmission within families revealed by molecular typing. J Clin Microbiol (2000) 1.25
Large-scale screening of human sera with cytomegalovirus recombinant antigens. J Clin Microbiol (1990) 1.25
Mass spectrometric identification of a naturally processed melanoma peptide recognized by CD8+ cytotoxic T lymphocytes. J Exp Med (1995) 1.24
Lymphoma of the spinal extradural space. Cancer (1976) 1.23
Reduced pulmonary function is associated with central arterial stiffness in men. Am J Respir Crit Care Med (2001) 1.23
Specific cytotoxic T lymphocyte responses against Melan-A/MART1, tyrosinase and gp100 in vitiligo by the use of major histocompatibility complex/peptide tetramers: the role of cellular immunity in the etiopathogenesis of vitiligo. J Invest Dermatol (2001) 1.21
Role of protein kinase C and the Na+/H+ antiporter in suppression of apoptosis by granulocyte macrophage colony-stimulating factor and interleukin-3. J Biol Chem (1992) 1.19
Does living on a farm during childhood protect against asthma, allergic rhinitis, and atopy in adulthood? Am J Respir Crit Care Med (2001) 1.19
Angiogenic activity of cervical carcinoma: assessment by functional magnetic resonance imaging-based parameters and a histomorphological approach in correlation with disease outcome. Clin Cancer Res (1998) 1.17
Cell volume regulation in liver. Ren Physiol Biochem (1989) 1.15
Identification of a unique Helicobacter species by 16S rRNA gene analysis in an abdominal abscess from a patient with X-linked hypogammaglobulinemia. J Clin Microbiol (2000) 1.15
Uterine cervical carcinoma: comparison of standard and pharmacokinetic analysis of time-intensity curves for assessment of tumor angiogenesis and patient survival. Cancer Res (1998) 1.14
Plants used by the Cree Nation of Eeyou Istchee (Quebec, Canada) for the treatment of diabetes: A novel approach in quantitative ethnobotany. J Ethnopharmacol (2005) 1.13
Multivariate independent prognostic factors in endometrial carcinoma: a clinicopathologic study in 181 patients: 10 years experience at the Department of Obstetrics and Gynecology of the Mainz University. Int J Gynecol Cancer (2003) 1.12
vacA genotypes and genetic diversity in clinical isolates of Helicobacter pylori. Clin Diagn Lab Immunol (1998) 1.10
Supportive care management of brain metastases: what is known and what we need to know. Conference proceedings of the National Cancer Institute of Canada (NCIC) Workshop on Symptom Control in Radiation Oncology. Clin Oncol (R Coll Radiol) (2003) 1.09
Morphological, immunohistochemical and biochemical characterization of 6 newly established human ovarian carcinoma cell lines. Int J Cancer (1992) 1.08
Stable and unstable amoxicillin resistance in Helicobacter pylori: should antibiotic resistance testing be performed prior to eradication therapy? J Clin Microbiol (1999) 1.07
Angiogenesis of uterine cervical carcinoma: characterization by pharmacokinetic magnetic resonance parameters and histological microvessel density with correlation to lymphatic involvement. Cancer Res (1997) 1.04
Product of the steel locus suppresses apoptosis in hemopoietic cells. Comparison with pathways activated by granulocyte macrophage colony-stimulating factor. J Biol Chem (1994) 1.04
The presence of HPV DNA in cervical cancer: correlation with clinico-pathologic parameters and prognostic significance: 10 years experience at the Department of Obstetrics and Gynecology of the Mainz University. Int J Gynecol Cancer (2001) 1.04
Clonally diverse CTL response to a dominant viral epitope recognizes potential epitope variants. J Immunol (2001) 1.03
Intratumoral pO2 histography as predictive assay in advanced cancer of the uterine cervix. Adv Exp Med Biol (1994) 1.03
Dual T cell receptor beta chain expression on human T lymphocytes. J Exp Med (1995) 1.03
Changes in airway inflammation following nasal allergic challenge in patients with seasonal rhinitis. Allergy (2006) 1.03
Implementing an effective intervention for problem drinkers on medical wards. Gen Hosp Psychiatry (2003) 1.02
Impact of MHC class I alleles on the M. tuberculosis antigen-specific CD8+ T-cell response in patients with pulmonary tuberculosis. Genes Immun (2007) 1.02
Usefulness of immunohistochemical staining for p53 in the prognosis of breast carcinomas: correlations with established prognosis parameters and with the proliferation marker, MIB-1. Gynecol Oncol (1995) 1.02
Deficient expression of components of the MHC class I antigen processing machinery in human cervical carcinoma. Int J Oncol (2001) 1.01
Cl(-)-HCO3- exchanger in isolated rat hepatocytes: role in regulation of intracellular pH. Am J Physiol (1991) 1.00
Regulatory volume decrease stimulates bile flow, bile acid excretion, and exocytosis in isolated perfused rat liver. Am J Physiol (1992) 0.99
Immunohistochemical evaluation of growth fractions in human breast cancers using monoclonal antibody Ki-67. Breast Cancer Res Treat (1991) 0.98
Growth fractions (Ki-67) in primary breast cancers, with particular reference to node-negative tumors. Cancer Detect Prev (1995) 0.97
Benzydamine for prophylaxis of radiation-induced oral mucositis in head and neck cancers: a double-blind placebo-controlled randomized clinical trial. Eur J Cancer Care (Engl) (2009) 0.96
Cervical carcinoma: standard and pharmacokinetic analysis of time-intensity curves for assessment of tumor angiogenesis and patient survival. MAGMA (1999) 0.95
MHC class II tetramer guided detection of Mycobacterium tuberculosis-specific CD4+ T cells in peripheral blood from patients with pulmonary tuberculosis. Scand J Immunol (2007) 0.95
Clonal expansion of Melan A-specific cytotoxic T lymphocytes in a melanoma patient responding to continued immunization with melanoma-associated peptides. Int J Cancer (2000) 0.95
Staging of invasive cervical carcinoma and of pelvic lymph nodes by high resolution MRI with a phased-array coil in comparison with pathological findings. J Comput Assist Tomogr (1998) 0.95
FDG PET evaluation of granular cell tumor of the breast. J Nucl Med (1998) 0.94
Autologous human dendriphages pulsed with synthetic or natural tumor peptides elicit tumor-specific CTLs in vitro. J Immunother (1998) 0.94
Rapid identification of local T cell expansion in inflammatory organ diseases by flow cytometric T cell receptor Vbeta analysis. J Immunol Methods (2000) 0.91
Glutathione, glutathione S-transferase alpha and pi, and aldehyde dehydrogenase content in relationship to drug resistance in ovarian cancer. Gynecol Oncol (1997) 0.91
Reduced T-cell receptor CD3zeta-chain protein and sustained CD3epsilon expression at the site of mycobacterial infection. Immunology (2001) 0.91
Longitudinal analysis of the T-cell receptor (TCR)-VA and -VB repertoire in CD8+ T cells from individuals immunized with recombinant hepatitis B surface antigen. Clin Exp Immunol (2002) 0.90
Glutathione S-transferase T1 and M1 gene defects in ovarian carcinoma. Cancer Lett (1998) 0.90
Diverse expansion potential and heterogeneous avidity in tumor-associated antigen-specific T lymphocytes from primary melanoma patients. Eur J Immunol (2001) 0.90
Tumor vascularity--a novel prognostic factor in advanced cervical carcinoma. Gynecol Oncol (1995) 0.90
Reactivity of mouse T-cell hybridomas expressing human Vbeta gene segments with staphylococcal and streptococcal superantigens. Infect Immun (1996) 0.90
The mask rhinoplasty: a technique for the treatment of Binder's syndrome and related disorders. Plast Reconstr Surg (1993) 0.90
Cloning and characterization of major antigenic determinants of human cytomegalovirus Ad169 seen by the human immune system. Arch Virol (1990) 0.90
Interleukin-12 and B7.1 co-stimulation cooperate in the induction of effective antitumor immunity and therapy of established tumors. Eur J Immunol (1996) 0.90
Contribution of c-erbB-2 and topoisomerase IIalpha to chemoresistance in ovarian cancer. Cancer Res (1999) 0.89
Immunophenotypic and immunogenotypic characteristics of TCRgammadelta+ T cell acute lymphoblastic leukemia. Leukemia (1999) 0.89
Single versus multiple fractions of palliative radiotherapy for bone metastases: a randomized clinical trial in Iranian patients. Curr Oncol (2008) 0.88
Secretion of disulfide-linked human T-cell receptor gamma delta heterodimers. J Biol Chem (1993) 0.88
Desloratadine improves quality of life and symptom severity in patients with allergic rhinitis. Allergy (2007) 0.88
Expression of tenascin in human cervical cancer--association of tenascin expression with clinicopathological parameters. Gynecol Oncol (1999) 0.87
Multiple melanoma-associated epitopes recognized by HLA-A3-restricted CTLs and shared by melanomas but not melanocytes. J Immunol (1996) 0.87
[Autosomal trisomia in a calf with brachygnathia inferior and ascites congenitus]. Dtsch Tierarztl Wochenschr (1968) 0.87
Perineal excision of a large angiomyxoma in a young woman following magnetic resonance and angiographic imaging. Gynecol Oncol (2001) 0.87
Erratum to: Clinician's guide to prevention and treatment of osteoporosis. Osteoporos Int (2015) 0.87
Antigen-driven T-cell selection in patients with cervical cancer as evidenced by T-cell receptor analysis and recognition of autologous tumor. Clin Diagn Lab Immunol (2002) 0.86
Expression analysis and functional activity of interleukin-7 splice variants. Genes Immun (2008) 0.86
Monoclonal TCR mRNA transcripts are preferentially detected in the TCR variable alpha chain in CD8(+) T-lymphocytes: implications for immunomonitoring. Int J Mol Med (1999) 0.86